And the posting is now live! Let me know if you have any questions about the ID Pharmacist/Clinical Coordinator ASP position.
https://t.co/MdYP8EksMl
#IDX#IDTwitter @TwitteRX
@raneempallotta Empirically our hospitals have been at 3.375 Q8 EI. Now increasing to 4.5 Q8 EI for confirmed MIC of 16. Considering increasing to 4.5 for empiric pseudomonas dosing but < 10% of our PsA isolates locally have MICs of 16 of greater
🆕️🔥 Single centre cohort study @StanfordASP@bluPharmD@DHpharmd &🌟s*
In immunocompromised pts with Invasive Mucormycosis neither upfront nor salvage antifungal combo Rx was associated with a difference in 6 week mortality compared to monotherapy
https://t.co/wx4aEnv5Ot
Calling all PGY1s interested in infectious diseases🚨🦠We are recruiting for our next ID PGY2 resident at @ProvOregonIDASP in Portland, OR🌲⛰️
Schedule a 30-min virtual session at the link below or meet with us at PPS for more info 👇🏼 https://t.co/PMxca6aANT
Calling all PGY1s interested in infectious diseases🚨🦠We are recruiting for our next ID PGY2 resident at @ProvOregonIDASP in Portland, OR🌲⛰️
Schedule a 30-min virtual session at the link below or meet with us at PPS for more info 👇🏼 https://t.co/PMxca6aANT
@PharmaSpence @ryankshields has papers describing pip-tazo regaining susceptibility following resistance development to C/T. Not sure about FDC though! https://t.co/kKuXAOmHaT We’ve seen this occur a few times at MDA, imi-rel may be worth testing?
Pursuing ID PGY2 in phase 2 of the @ASHPOfficial match?!? Check us out! 🦠
We still have a spot available @CRMHRxResidency & will be in Phase 2 of the Match!
Check out our program: https://t.co/IXPBaUDuDx
DM if there are any questions!
#IDTwitter#RxTwitter
The @OURxResidency PGY-2 ID pharmacy residency will be going into phase 2 of the match. Want to train at an AMC with a variety of experiences including OPAT and transplantID? Please share. https://t.co/W4bfVvPN6h
Want to do an ASHP-accredited ID residency at an academic medical center and didn’t match (or participate) in Phase I? @UMMCPharmacy has a PGY2 ID spot that will be participating in Phase II. We’d love to have your application! Contact me with questions. https://t.co/5Kp4fR5hge
Seeking contributors for a new #WikiGuideline project – Care of Patients Who Inject Drugs (#PWID). Come be part of our team and help improve the care of these marginalized patients. Sign up here by 4/1/23: https://t.co/ibZXjf3eGV
@NNolanMD@rachelpbaden#SUD#PWUD#Addiction
A 🆕️⚡️Small retrospective single study in immunocompromised patients
Poor clinical outcomes of Piperacillin/tazobactam Vs cefepime or carbapenems for
AmpC-producing organisms
MERINO 2 no definitive answer!
Meta/Dr. Lee? No difference
An RCT ? #IDTwitter https://t.co/L0OjPDyAyN